Becton Dickinson (BDX) — insider trading
Health Care · NYSE
Becton Dickinson (BDX) has 28 reported SEC Form 4 insider transactions in our data, including 11 open-market sales among the most recent 28 (latest 2026-09-28).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | Feld Michael | Officer (EVP, Chief Revenue Officer) | Open-market sale | 76 | $183.70 | $14.0K | Form 4 |
| 2026-09-02 | Roque Vitor | Officer (EVP & Chief Financial Officer) | Shares withheld for taxes / exercise cost | 190 | — | $0 | Form 4 |
| 2026-08-26 | Feld Michael | Officer (EVP, Chief Revenue Officer) | Open-market sale | 165 | $188.49 | $31.1K | Form 4 |
| 2026-08-20 | Feld Michael | Officer (EVP, Chief Revenue Officer) | Shares withheld for taxes / exercise cost | 1,049 | — | $0 | Form 4 |
| 2026-08-13 | Polen Thomas E Jr | Director, Officer (Chairman, CEO and President) | Option exercise / conversion (derivative) | 43,278 | — | $0 | Form 4 |
| 2026-08-13 | Polen Thomas E Jr | Director, Officer (Chairman, CEO and President) | Open-market sale | 4,152 | $185.00 | $768.1K | Form 4 |
| 2026-08-13 | Polen Thomas E Jr | Director, Officer (Chairman, CEO and President) | Disposition to the issuer | 39,126 | $185.00 | $7.24M | Form 4 |
| 2026-08-13 | Polen Thomas E Jr | Director, Officer (Chairman, CEO and President) | Option exercise / conversion | 43,278 | $167.25 | $7.24M | Form 4 |
| 2026-08-11 | Goette Roland | Officer (EVP and President, EMEA) | Open-market sale | 2,438 | $180.84 | $440.9K | Form 4 |
| 2026-08-06 | Byington Carrie L | Director | Grant / award / vesting (derivative) | 94 | $165.62 | $15.6K | Form 4 |
| 2026-08-06 | Huffines Robert Luther | Director | Grant / award / vesting (derivative) | 189 | $165.62 | $31.3K | Form 4 |
| 2026-07-27 | Feld Michael | Officer (EVP, Chief Revenue Officer) | Open-market sale | 75 | $157.13 | $11.8K | Form 4 |
| 2026-07-02 | Muhsin Bilal | Officer (EVP & President Connected Care) | Shares withheld for taxes / exercise cost | 1,935 | — | $0 | Form 4 |
| 2026-07-01 | Muhsin Bilal | Officer (EVP & President Connected Care) | Grant / award / vesting | 14,342 | — | $0 | Form 4 |
| 2026-06-26 | Feld Michael | Officer (EVP, Chief Revenue Officer) | Open-market sale | 75 | $152.80 | $11.5K | Form 4 |
| 2026-06-24 | Garrison Michael David | Officer (EVP & Pres Med.Essntl&BioPharm) | Open-market sale | 1,100 | $145.66 | $160.2K | Form 4 |
| 2026-06-10 | Garrison Michael David | Officer (EVP & Pres Med.Essntl&BioPharm) | Open-market sale | 1,100 | $151.48 | $166.6K | Form 4 |
| 2026-06-01 | Polen Thomas E Jr | Director, Officer (Chairman, CEO and President) | Option exercise / conversion (derivative) | 20,209 | — | $0 | Form 4 |
| 2026-06-01 | Polen Thomas E Jr | Director, Officer (Chairman, CEO and President) | Open-market sale | 2,764 | $146.35 | $404.5K | Form 4 |
| 2026-06-01 | Polen Thomas E Jr | Director, Officer (Chairman, CEO and President) | Disposition to the issuer | 17,445 | $146.15 | $2.55M | Form 4 |
| 2026-06-01 | Polen Thomas E Jr | Director, Officer (Chairman, CEO and President) | Option exercise / conversion | 20,209 | $126.16 | $2.55M | Form 4 |
| 2026-06-01 | Menziuso Peter | Officer (EVP and President, BDI) | Grant / award / vesting | 14,258 | — | $0 | Form 4 |
| 2026-05-26 | Feld Michael | Officer (EVP, Chief Revenue Officer) | Open-market sale | 75 | $147.35 | $11.1K | Form 4 |
| 2026-05-08 | Byington Carrie L | Director | Grant / award / vesting (derivative) | 105 | $149.04 | $15.6K | Form 4 |
| 2026-05-08 | Huffines Robert Luther | Director | Grant / award / vesting (derivative) | 210 | $149.04 | $31.3K | Form 4 |
| 2026-05-07 | Roque Vitor | Officer (EVP & Chief Financial Officer) | Grant / award / vesting | 1,721 | — | $0 | Form 4 |
| 2026-04-27 | Feld Michael | Officer (EVP, Chief Revenue Officer) | Open-market sale | 74 | $151.94 | $11.2K | Form 4 |
| 2026-04-06 | Neal Shana Carol | Officer (EVP and Chief People Officer) | Shares withheld for taxes / exercise cost | 1,146 | — | $0 | Form 4 |
Ask the chat about BDX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Becton Dickinson (BDX).
Last updated 2026-09-28 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.